Skip to main content
. 2010 Mar;95(3):388–397. doi: 10.3324/haematol.2009.016063

Table 2.

Apoptosis rate, measured by terminal transferase dUTP nick-end labeling assay, after treatment with imatinib, nilotinib and transfection with BCR-ABL siRNA or co-treatment with BCR-ABL siRNA and imatinib or nilotinib in tyrosine kinase inhibitor-sensitive and –resistant BCR-ABL oligoclonal cell lines.

graphic file with name 95388.tab2.jpg